Iceland· IS-EU/1/99/123/005-007
Renagel
A sevelamer product containing sevelamerum inn, registered in Iceland by Sanofi Winthrop Industrie. The same ATC class is registered in 18 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Sevelamer is registered in 18 of 19 countries.
Countries holding a registration under ATC V03AE02 (sevelamer), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 11 of them publish a price we can compare per daily dose
Sevelamer · ATC V03AE02
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of sevelamer costs, country by country.
Normalised to the WHO defined daily dose (6.4 g), the median price runs from $3.42 in France to $9.10 in Switzerland — a ×2.7 gap.
- 5 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Sevelamer · price per daily dose (6.4 g)
USD · FX 28 Sept 2026
- CH Switzerland$9.10
- ES Spain$6.97
- IT Italy$5.92
- US United States$5.56 (acquisition cost)
- FR France$3.42
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Sevelamerum INN
- Manufacturer
- Sanofi Winthrop Industrie
- Country
- Iceland (IS)
- ATC code
- V03AE02
- ATC class
- Sevelamer
- Defined daily dose
- 6.4 g, O
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
293 interactions on record for sevelamer.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Sevelamer · interactions on record
293 records
- 2 severe
- 31 moderate
- 258 info
Most severe, free to view
- ErdafitinibL01EN01severe
- ErdafitinibL01EX16severe
- ErgocalciferolA11CC01moderate
- DihydrotachysterolA11CC02moderate
2 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Sevelamer in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainHIDROCLORURO DE SEVELAMERO WAYMADE 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULAWaymade B.V.
- IrelandRenagel 400 mg Film-coated tabletSanofi Winthrop Industrie
- NetherlandsRenagel 400 mg filmomhulde tablettenSanofi Winthrop Industrie
- PolandRenagelSanofi Winthrop Industrie
- United KingdomRenagel 403mg capsulesGenzyme Therapeutics Ltd
- FranceCHLORHYDRATE DE SEVELAMER WAYMADE 800 mg, comprimé pelliculéWAYMADE (PAYS-BAS)
- ItalyRENAGEL*180 cpr rivestite 800 mg flaconeSANOFI WINTHROP INDUSTRIE
- SwitzerlandRenagel, comprimés pelliculésSanofi-Aventis (Suisse) SA
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/187f9c13-6877-4929-b443-4724cd9ea85f GET /v1/drugs/187f9c13-6877-4929-b443-4724cd9ea85f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Filmuhúðuð tafla",
"source": "lyfjastofnun",
"atc_raw": "V03AE02",
"marketed": false,
"strength": "400 mg",
"ma_number": "EU/1/99/123/005-007",
"substance": "Sevelamerum INN",
"other_info": null,
"legal_status": "(R) Lyfseðilsskylt",
"ma_issued_serial": "37211"
}See everything about sevelamer.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.